glutathione switch persister cells Frontiers Glutathione responsive nanomedicine leverages tumor
Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link Redox signaling in drug tolerant persister cells as an emerging therapeutic target eBioMedicine How pancreatic cancer survives ferroptosis? Pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations exhibit relative resistance to iron dependent form of cell death, ferroptosis, compared with other tumor types but the mechanisms remain Drug tolerant persister cells in cancer: the cutting edges and future directions Nature Reviews Clinical Oncology Low GPX4 drives a sustained drug tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation ScienceDirect
Pay in 4 interest-free payments of $7.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



